For most, the idea that you might don a headset to zap your depression away or use electromagnetic pulses to sharpen your cognition seems better placed in a science fiction novel from the 1930s than ...

Please provide your email address to receive an email when new articles are posted on . Focal cortex stimulation with an implantable device reduced seizure activity in more than 50% of participants at ...

HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation ...

Ilia Topuria isn’t resorting to typical training in preparation for the UFC’s special Freedom 250 event on June 14, 2026. All ...

Scientia, a consultant specializing in growth strategies for companies, predicts strong future growth in the market for implanted technologies that deliver electrical stimulation for treatment for ...

ImThera Medical Inc. put to bed more than $1 million of a possible $2.2 million funding round that will go toward completing clinical trials of an implantable neurostimulation device for sleep apnea.

HOUSTON, TEXAS, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its ...

Calif.-based DyAnsys, a medical device company specializing in the autonomous nervous system, announced Primary Relief, its percutaneous electrical nerve stimulator (PENS) system, received approval by ...

Please provide your email address to receive an email when new articles are posted on . Olympic Ophthalmics announced that the FDA granted the 510(K) request for its second-generation iTEAR100 device, ...